These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20546699)

  • 1. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.
    Otto MW; McHugh RK; Simon NM; Farach FJ; Worthington JJ; Pollack MH
    Behav Res Ther; 2010 Aug; 48(8):720-7. PubMed ID: 20546699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.
    Otto MW; Pollack MH; Sachs GS; Reiter SR; Meltzer-Brody S; Rosenbaum JF
    Am J Psychiatry; 1993 Oct; 150(10):1485-90. PubMed ID: 8379551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?
    Spiegel DA; Bruce TJ; Gregg SF; Nuzzarello A
    Am J Psychiatry; 1994 Jun; 151(6):876-81. PubMed ID: 8184997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC
    J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patients.
    Otto MW; Pollack MH; Meltzer-Brody S; Rosenbaum JF
    Psychopharmacol Bull; 1992; 28(2):123-30. PubMed ID: 1355299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder.
    Bruce TJ; Spiegel DA; Gregg SF; Nuzzarello A
    Am J Psychiatry; 1995 Aug; 152(8):1156-60. PubMed ID: 7625463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    Klein E; Colin V; Stolk J; Lenox RH
    Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder.
    Roy-Byrne P; Russo J; Pollack M; Stewart R; Bystrisky A; Bell J; Rosenbaum J; Corrigan MH; Stolk J; Rush AJ; Ballenger J
    Psychol Med; 2003 Apr; 33(3):511-8. PubMed ID: 12701671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: a long-term follow-up of the Peoria and Dartmouth studies.
    Bruce TJ; Spiegel DA; Hegel MT
    J Consult Clin Psychol; 1999 Feb; 67(1):151-6. PubMed ID: 10028220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication discontinuation in panic disorder.
    Ballenger JC; Pecknold J; Rickels K; Sellers EM
    J Clin Psychiatry; 1993 Oct; 54 Suppl():15-21; discussion 22-4. PubMed ID: 8262887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine discontinuation difficulties in panic disorder: conceptual model and outcome for cognitive-behavior therapy.
    Otto MW; Hong JJ; Safren SA
    Curr Pharm Des; 2002; 8(1):75-80. PubMed ID: 11812251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia.
    Westra HA; Stewart SH; Conrad BE
    J Anxiety Disord; 2002; 16(3):233-46. PubMed ID: 12214810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder.
    Schmidt NB; Wollaway-Bickel K; Trakowski JH; Santiago HT; Vasey M
    Behav Res Ther; 2002 Jan; 40(1):67-73. PubMed ID: 11762428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC; Swinson RP; Kuch K; Lewis CP
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder.
    Otto MW; Safren SA; Pollack MH
    J Anxiety Disord; 2004; 18(1):69-87. PubMed ID: 14725869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder.
    Gelder MG
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):2S-5S. PubMed ID: 9872706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment.
    Nardi AE; Freire RC; Valença AM; Amrein R; de Cerqueira AC; Lopes FL; Nascimento I; Mezzasalma MA; Veras AB; Sardinha A; de Carvalho MR; da Costa RT; Levitan MN; de-Melo-Neto VL; Soares-Filho GL; Versiani M
    J Clin Psychopharmacol; 2010 Jun; 30(3):290-3. PubMed ID: 20473065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
    Moroz G; Rosenbaum JF
    J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication discontinuation in panic disorder.
    Ballenger JC
    J Clin Psychiatry; 1992 Mar; 53 Suppl():26-31. PubMed ID: 1548252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.